-
-
Call more information
660-596-2224 -
Keya A. Locke, MD, MBA et al ASA Monitor July 2023, Vol. 87, 14–15. “The operating room should be at the disposal of the surgeons 24/7, no questions asked.” “Every day at 3 p.m. it’s like rats scurrying off the deck of the Titanic, and we can’t get any work done.” “1:30 p.m. is the bewitching […]
Read MoreASA Monitor July 2023, Vol. 87, 7. Which of the following immunosuppressive drugs is MOST likely to cause renal dysfunction? □ (A) Tacrolimus □ (B) Mycophenolate mofetil □ (C) Basiliximab Immunosuppressant drugs are used to prevent or treat allograft rejection. Most of these drugs act during the induction phase of the immunological response, reducing lymphocyte proliferation. Some of them […]
Read MoreAuthors: Judith Jurin Semo, JD et al ASA Monitor July 2023, Vol. 87, 17–18. Restrictive covenants or noncompetes in employment are a contentious topic (ASA Monitor 2020;84:1-18). If a proposed rule issued in January 2023 by the Federal Trade Commission (FTC) is adopted, most employers in the United States will be foreclosed from requiring employees to […]
Read MoreAuthors: James L. Hill, Jr., MD, MBA, CPE, FASA, FACHE et al ASA Monitor July 2023, Vol. 87, 16–18. Physicians know the sacrifice and devotion needed to excel during college, medical school, and residency. While the path to becoming a physician is defined, the career journey after completing graduate medical education can become unclear. Professional development […]
Read MoreAUTHORS: Dinesh Ramaiah MBBS et al Anesthesia Patient Safety Foundation Volume 38, No. 2 • June 2023 TO THE EDITOR We appreciate the reprinting in the APSF Newsletter of the article from Anesthesia & Analgesia, (June 2022 • Volume 134 • Number 6, pages 1192–1200), entitled “Pro-Con Debate: Monitored Anesthesia Care Versus General Endotracheal Anesthesia for Endoscopic Retrograde Cholangiopancreatography” […]
Read More